explore -WSS

explore

author：knowledge 2025-08-19 15:00:51 - browse：246

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Addressing health care workers' trauma can help fight burnout

knowledge

WSS

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Radiology is caught between AI's potential and concern for patients

As a primary care physician, here's how I hope to partner with AI

UnitedHealth argues against case alleging wrongful AI care denials

Americans' trust in science, scientist continues decline: Report

Study finds gene variants tied to breast cancer risk in Black women

knowledge

explore

entertainment

In age of alternative facts, a scholarly course on calling out crap

Scrutiny of post

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth argues against case alleging wrongful AI care denials

Virginia high school admissions case could be legal follow

In diabetes hearing, Sanders takes on a new foe: food makers

ChatGPT in medicine: STAT answers readers' burning questions

Radiology is caught between AI's potential and concern for patients

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The woman behind the Dana Farber

explore

Study finds gene variants tied to breast cancer risk in Black women

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

After sickle

Cue Health, Covid

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

In diabetes hearing, Sanders takes on a new foe: food makers

focus

knowledge

focus

Wikipedia